Stefan Oelrich - Bayer AG Head Management
| BAYN Stock | EUR 28.20 0.12 0.42% |
Insider
Stefan Oelrich is Head Management of Bayer AG NA
| Age | 55 |
| Phone | 49 214 30 1 |
| Web | https://www.bayer.com |
Bayer AG Management Efficiency
The company has return on total asset (ROA) of 0.0576 % which means that it generated a profit of $0.0576 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.13 %, meaning that it generated $0.13 on every $100 dollars invested by stockholders. Bayer AG's management efficiency ratios could be used to measure how well Bayer AG manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Thomas Schinecker | Roche Holding Ltd | 48 | |
| Anabella Villalobos | Biogen Inc | 64 | |
| Kenneth Frazier | Merck Co | 67 | |
| Nancy Grygiel | Amgen Inc | 55 | |
| Pascale Schmidt | Roche Holding Ltd | 50 | |
| Jennifer Mauer | Merck Co | N/A | |
| Jennifer Zachary | Merck Co | 45 | |
| Caroline Litchfield | Merck Co | 54 | |
| Peter Griffith | Amgen Inc | 64 | |
| Michael CPA | Biogen Inc | 59 | |
| David MD | Amgen Inc | 60 | |
| Bruno Eschli | Roche Holding Ltd | N/A | |
| William Anderson | Roche Holding Ltd | 57 | |
| Ginger Gregory | Biogen Inc | 55 | |
| Murdo Gordon | Amgen Inc | 56 | |
| Arvind Sood | Amgen Inc | N/A | |
| Susan Esq | Biogen Inc | 66 | |
| Robin Kramer | Biogen Inc | 57 | |
| Johannes MD | Roche Holding Ltd | 66 | |
| Richard DeLuca | Merck Co | 60 | |
| Claudia Bockstiegel | Roche Holding Ltd | 59 | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0576 |
Bayer AG NA Leadership Team
Elected by the shareholders, the Bayer AG's board of directors comprises two types of representatives: Bayer AG inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bayer. The board's role is to monitor Bayer AG's management team and ensure that shareholders' interests are well served. Bayer AG's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bayer AG's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sarena Lin, Labor Officer | ||
| Oliver Maier, Head Relations | ||
| Gabriel Harnier, Patents Law | ||
| Heiko Schipper, Member Division | ||
| Rodrigo Santos, Member Division | ||
| Michael Preuss, Gov Communications | ||
| Stefan Oelrich, Head Management | ||
| Wolfgang Nickl, CFO Board | ||
| BerndPeter Bier, Head Taxes | ||
| Werner Baumann, CEO Board |
Bayer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bayer AG a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0576 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 83.74 B | |||
| Shares Outstanding | 982.42 M | |||
| Shares Owned By Institutions | 47.06 % | |||
| Price To Earning | 11.34 X | |||
| Price To Book | 1.37 X | |||
| Price To Sales | 1.00 X |
Currently Active Assets on Macroaxis
| SGC | Superior Uniform Group | |
| VLN | Valens | |
| GNFT | Genfit | |
| GAIA | Gaia Inc | |
| BLBD | Blue Bird Corp |
Other Information on Investing in Bayer Stock
Bayer AG financial ratios help investors to determine whether Bayer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer AG security.